INDSWFTLABNSEInd-Swift Laboratories Limited· PharmaceuticalsLowNeutral
Announced Fri, 14 Nov · 19:13 IST

Monitoring Agency report for the Quarter ended September 30, 2025 in respect to fund raised through Preferential Issue.

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ind-Swift Laboratories has submitted the quarterly Monitoring Agency report for the three months ended September 30, 2025. This report tracks how the company has utilised the money it raised earlier through a Preferential Issue (allotment of shares to select investors at a fixed price). Under SEBI rules, companies must appoint an independent Monitoring Agency to certify that the funds are being used for the purposes disclosed at the time of issue. The filing itself is a routine regulatory compliance submission, and investors would need to read the attached report to see whether the proceeds were deployed as planned or if any deviations were flagged.

Likely market impact

This is a routine compliance filing and is largely neutral for shareholders. Investors should check the attached report for any deviation from the stated use of proceeds, which could be a mild red flag if reported.